Evaluating Multiparametric Ultrasound Imaging for Pancreatic Cancer Risk and Thyroid Nodule Assessment

What this Trial Is About

Researchers are evaluating how well multiparametric ultrasound mpUS imaging can examine and provide information about cancerous and non-cancerous tissues. This study compares mpUS, which combines different ultrasound methods to show detailed tissue structure and blood flow, with standard ultrasound and other tests. The goal is to see if mpUS can offer a more accurate assessment, especially for pancreatic cancer and thyroid nodules. Participants will receive additional mpUS imaging during their standard ultrasound procedures, which adds about 5 to 15 minutes of scan time. There are three groups patients at high risk for pancreatic cancer undergoing endoscopic ultrasound, patients with pancreatic ductal adenocarcinoma receiving endoscopic ultrasound-guided biopsies, and patients having thyroid nodule biopsies. Healthy volunteers without cancer or thyroid nodules may also join. During the study, participants will undergo mpUS imaging alongside their usual care scans. Researchers will collect the extra ultrasound data to evaluate the feasibility of mpUS imaging. The main outcome is assessing how well mpUS works during the imaging procedures. This study is non-randomized, has no masking, and will continue until November 2027. Participants may be followed up as agreed, and the total added scan time is brief.

A Study of Multiparametric Ultrasound Imaging Methods